Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada

• Main Authors: Sean Wharton (Author), Christiane L. Haase (Author), Elham Kamran (Author), Aiden Liu (Author), Johanna Mancini (Author), Drew Neish (Author), Arash Pakseresht (Author), G Sarah Power (Author), Rebecca A. G. Christensen (Author)
• Format: Book
• Published: Wiley, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary Objective Liraglutide 3.0 mg is associated with clinically significant weight loss in clinical trials, but real‐world data are lacking. In this analysis, weight loss and persistence outcomes with liraglutide 3.0 mg were assessed across obesity classes, in a real‐world clinical setting. Metho...